US Patent Issued to GUANGZHOU ZHIYI BIOTECHNOLOGY on Oct. 28 for "Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,746, issued on Oct. 28, was assigned to GUANGZHOU ZHIYI BIOTECHNOLOGY Co. LTD. (Guangzhou, China).

"Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome" was invented by Yangyang Liu (Guangzhou, China), Lijun Zheng (Guangzhou, China), Ping Li (Guangzhou, China), Gaobo Kuang (Guangzhou, China), Xiaomin Yi (Guangzhou, China), Ye Wang (Guangzhou, China) and Fachao Zhi (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided here relates to use of Akkermansia muciniphila or a composition containing Akkermansia muciniphila in preparation of a pharm...